These patients suffer from abnormalities in mineral metabolism, caused by an imbalance of calcification promoters (e.g., calcium and phosphate) and inhibitors (e.g., matrix Gla protein (MGP) and fetuin-A) [6] and termed ‘mineral bone disorder’ (MBD). This evidence concerns the gene MGP and abnormal mineralization disorder.